Rheumatoid Arthritis Clinical Trials in Houston

Showing 1121-1140 of 1,660 trials

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

NCT03052075

The primary objective of this study is to estimate the percent change in baseline bone mineral density (BMD) starting at one year after parathyroidectomy and all the following available dates in patients presenting with primary hyperparathyroidism. The secondary objective is to identify patient factors associated with change in BMD.

Primary Hyperparathyroidism

M.D. Anderson Cancer Center250 participantsStarted Sep 2014

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01664897

This pilot phase II trial studies how well erlotinib hydrochloride works in treating patients with relapsed or refractory acute myeloid leukemia. Erlotinib hydrochloride may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+8 more

M.D. Anderson Cancer Center29 participantsStarted May 2013

Houston, Texas, United States

TERMINATEDPhase 3< 1 mile

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

NCT01708603

The purpose of this study is to assess the safety and efficacy of brodalumab at two different doses

Moderate to Severe Plaque Psoriasis

Bausch Health Americas, Inc.1,831 participantsStarted Aug 2012

Birmingham, Alabama, United States • Tucson, Arizona, United States • Hot Springs, Arkansas, United States +150 more locations

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

Rheumatoid Arthritis Trials in Other Cities

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

EEG Based BCI for Upper Limb Rehabilitation in Stroke

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

SPRINT - Randomized Trial of Tibial Fracture Fixation

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

ImageReady(TM) MR Conditional Pacing System Clinical Study

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

MaxAn Post Market Surveillance Validation

Post Market Surveillance Study of the Wingspan Stent System

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

A Clinical Trial of IntensiVE Dialysis

Other Conditions in Houston